Differentiating COVID-associated myocarditis from other Diseases: Difference between revisions

Jump to navigation Jump to search
Mounika (talk | contribs)
Created page with "__NOTOC__ right|250px|link=https://www.wikidoc.org/index.php/COVID-19-associated_myocarditis {{CMG}}; {{AE}}{{MRV}} ==Overview== COVID-19-associat..."
 
Mounika (talk | contribs)
 
(6 intermediate revisions by the same user not shown)
Line 6: Line 6:


==Overview==
==Overview==
COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, including [[pneumonia]], [[acute respiratory distress syndrome]], [[heart failure]], and [[pulmonary embolism]].
COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac [[biomarkers]], [[ventricular dysfunction]] such as  including [[COVID-19-associated myocardial infarction|Acute Coronary Syndrome]], [[COVID-19-associated stress cardiomyopathy|Stress-induced cardiomyopathy]] ([[Takotsubo cardiomyopathy]]) and [[COVID-19-associated heart failure|Heart failure]].


==Differential Diagnosis==
==Differential Diagnosis==


COVID-19-associated myocarditis must be differentiated from [[pneumonia]], [[acute respiratory distress syndrome]], [[heart failure]], and [[pulmonary embolism]].
COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac [[biomarkers]], [[ventricular dysfunction]] such as  including [[COVID-19-associated myocardial infarction|acute coronary syndrome]], [[COVID-19-associated stress cardiomyopathy|stress-induced cardiomyopathy]] ([[takotsubo cardiomyopathy]]) and [[COVID-19-associated heart failure|heart failure]].
 
<small>
<small>
{|
{|
Line 31: Line 30:
!<small>Echocardiography</small>
!<small>Echocardiography</small>
!<small>CT scan and CMR</small>  
!<small>CT scan and CMR</small>  
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated myocarditis]]
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |
*[[Pericardial effusion]] may be detectable
| style="background: #F5F5F5; padding: 5px;" |
* Non-specific:may show nonspecific ST-T abnormalities, [[sinus tachycardia]] and [[conduction abnormalities]] (such as [[bundle branch block|bundle-branch blocks]] or [[atrioventricular block|atrioventricular conduction delays]])
| style="background: #F5F5F5; padding: 5px;" |
*Non-specific: In [[fulminant myocarditis]], cardiac chamber sizes are usually normal with an increased septal thickness (secondary to acute myocardial edema), whereas in acute [[myocarditis]] marked left [[ventricular]] dilation and normal wall thickness might be seen.
*[[Pericardial effusion]] may be be seen.
| style="background: #F5F5F5; padding: 5px;" |
*CMR: T2-weighted [[edema]] imaging shows the presence of “acute [[myocardial]] [[inflammation]]”. "Late gadolinium enhancement (LGE) imaging” can demonstrate [[myocardial]] damage.
| style="background: #F5F5F5; padding: 5px;" | Increased cardiac [[troponin]] level
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated myocardial infarction]]
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" |✔(Low-grade)
| style="background: #F5F5F5; padding: 5px;" |✔/-
| style="background: #F5F5F5; padding: 5px;" |✔/-
| style="background: #F5F5F5; padding: 5px;" |
*No specific X-ray findings
| style="background: #F5F5F5; padding: 5px;" |
*[[ST elevation MI]] ([[STEMI]])
*[[Non-ST elevation MI]] ([[NSTEMI]]) or Non Q wave
| style="background: #F5F5F5; padding: 5px;" |
*Localized wall motion abnormalities
*Diffuse hypokinesia 
*Left ventricular [[ejection fraction]] was lower than 50% in about 61% of the individuals.
| style="background: #F5F5F5; padding: 5px;" |
-
| style="background: #F5F5F5; padding: 5px;" | Increased cardiac [[troponin]] levels
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated stress cardiomyopathy]]
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |
*Takotsubo-shaped [[heart]], in which there is [[apical ballooning]] and narrowing of the [[proximal]] portion near the [[great vessels]].
| style="background: #F5F5F5; padding: 5px;" |
*[[ST elevation]] in the [[precordial leads]]
*[[T wave inversion]]
*[[Q wave]] formation
*[[QT prolongation]]
*New-onset [[Bundle branch block|bundle branch block (BBB)]]
*Rarely, malignant [[ventricular arrhythmias]] may be seen
| style="background: #F5F5F5; padding: 5px;" |
*[[Apical ballooning]]
*[[Apical]] or mid-segment [[dyskinesia]] or [[akinesia]]
*[[Left ventricular]] [[systolic dysfunction]]
* Reduced [[ejection fraction]]
| style="background: #F5F5F5; padding: 5px;" |
*CT: Regional abnormalities in the wall motion of the heart, along with absence of [[coronary atherosclerosis]].
*CMR: Absence of gadolinium hyper-enhancement; also shows absence of irreversible damage, regional wall abnormalities with extent and segmental LV dysfunction.
| style="background: #F5F5F5; padding: 5px;" | Increased cardiac [[troponin]] and [[pro-BNP]] level, transient increase in [[catecholamine]] levels.
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated heart failure|COVID-19-associated heart failure]]
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated heart failure|COVID-19-associated heart failure]]
Line 63: Line 126:
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*[[Lobar Consalidation]]
*[[Lobar Consolidation]]
| style="background: #F5F5F5; padding: 5px;" |  
| style="background: #F5F5F5; padding: 5px;" |  
*Prolonged PR interval
*Prolonged [[PR interval]]
*Transient T wave inversions
*Transient [[T wave]] inversions
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |  
| style="background: #F5F5F5; padding: 5px;" |  
*CT: [[Lobar Consalidation]]
*CT: [[Lobar Consolidation]]
| style="background: #F5F5F5; padding: 5px;" | Increased inflammatory markers, including [[ESR]], [[hs-CRP]]
| style="background: #F5F5F5; padding: 5px;" | Increased [[inflammatory markers]], including [[ESR]], hs-[[CRP]]
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated acute respiratory distress syndrome|COVID-19-associated acute respiratory distress syndrome
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated acute respiratory distress syndrome|COVID-19-associated acute respiratory distress syndrome]]
]]
| style="background: #F5F5F5; padding: 5px;" |✔  
| style="background: #F5F5F5; padding: 5px;" |✔  
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" |-
Line 84: Line 146:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |  
| style="background: #F5F5F5; padding: 5px;" |  
*Signs of RV dysfunction/RV dilatation may be seen.
*Signs of [[Right ventricle|RV]] dysfunction/[[Right ventricle|RV]] dilatation may be seen.
| style="background: #F5F5F5; padding: 5px;" |  
| style="background: #F5F5F5; padding: 5px;" |  
*CT: Bilateral [[ground-glass opacities]]
*CT: Bilateral [[ground-glass opacities]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated myocarditis]]
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |
*[[Pericardial effusion]] may be detectable
| style="background: #F5F5F5; padding: 5px;" |
* Non-specific:may show nonspecific ST-T abnormalities, [[sinus tachycardia]] and [[conduction abnormalities]] (such as bundle-branch blocks or atrioventricular conduction delays)
| style="background: #F5F5F5; padding: 5px;" |
*Non-specific: In [[fulminant myocarditis]], cardiac chamber sizes are usually normal with an increased septal thickness (secondary to acute myocardial edema), whereas in acute [[myocarditis]] marked left ventricular dilation and normal wall thickness might be seen.
*[[Pericardial effusion]] may be be seen.
| style="background: #F5F5F5; padding: 5px;" |
*CMR: T2-weighted edema imaging shows the presence of “acute myocardial inflammation”. "[[Late gadolinium enhancement (LGE)]] imaging” can demonstrate myocardial damage.
| style="background: #F5F5F5; padding: 5px;" | Increased cardiac [[troponin]]s level
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated pulmonary embolism]]
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated pulmonary embolism]]
| style="background: #F5F5F5; padding: 5px;" |✔ (Usually sudden-onset)
| style="background: #F5F5F5; padding: 5px;" |✔ (Usually sudden-onset)
| style="background: #F5F5F5; padding: 5px;" |✔ ([[Pleauritic]])
| style="background: #F5F5F5; padding: 5px;" |✔ ([[Pleuritic]])
| style="background: #F5F5F5; padding: 5px;" |✔ (If massive PE)
| style="background: #F5F5F5; padding: 5px;" |✔ (If massive PE)
| style="background: #F5F5F5; padding: 5px;" |✔ (Low-grade)
| style="background: #F5F5F5; padding: 5px;" |✔ (Low-grade)
Line 115: Line 159:
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*May show [[Fleischner sign]] (enlarged pulmonary artery), [[Hampton hump]], [[Westermark's sign]]
*May show [[Fleischner sign]] (enlarged [[pulmonary artery]]), [[Hampton hump]], [[Westermark's sign]]
| style="background: #F5F5F5; padding: 5px;" |  
| style="background: #F5F5F5; padding: 5px;" |  
* Non-specific:may show [[S1Q3T3]] pattern
* Non-specific:may show [[S1Q3T3]] pattern
| style="background: #F5F5F5; padding: 5px;" |  
| style="background: #F5F5F5; padding: 5px;" |  
*May show signs of RV strain, Rv dilatation, Rv dysfunction (if large PE)
*May show signs of [[Right ventricle|RV]] strain, [[Right ventricle|RV]] dilatation, [[Right ventricle|RV]] dysfunction (if large PE)
| style="background: #F5F5F5; padding: 5px;" |  
| style="background: #F5F5F5; padding: 5px;" |  
*On CT angiography: Intra-luminal filling defect
*On CT angiography: Intra-luminal filling defect

Latest revision as of 08:47, 24 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]


Overview

COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac biomarkers, ventricular dysfunction such as including Acute Coronary Syndrome, Stress-induced cardiomyopathy (Takotsubo cardiomyopathy) and Heart failure.

Differential Diagnosis

COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac biomarkers, ventricular dysfunction such as including acute coronary syndrome, stress-induced cardiomyopathy (takotsubo cardiomyopathy) and heart failure.

Diseases Symptoms Physical Examination Diagnostic tests Other Findings
Dyspnea on Exertion Chest Pain Hemoptysis Fever Tachypnea Tachycardia Chest X-ray ECG Echocardiography CT scan and CMR
COVID-19-associated myocarditis - Increased cardiac troponin level
COVID-19-associated myocardial infarction - ✔(Low-grade) ✔/- ✔/-
  • No specific X-ray findings
  • Localized wall motion abnormalities
  • Diffuse hypokinesia
  • Left ventricular ejection fraction was lower than 50% in about 61% of the individuals.

-

Increased cardiac troponin levels
COVID-19-associated stress cardiomyopathy - -
  • CT: Regional abnormalities in the wall motion of the heart, along with absence of coronary atherosclerosis.
  • CMR: Absence of gadolinium hyper-enhancement; also shows absence of irreversible damage, regional wall abnormalities with extent and segmental LV dysfunction.
Increased cardiac troponin and pro-BNP level, transient increase in catecholamine levels.
COVID-19-associated heart failure - - Increased NT-proBNP and cardiac troponins levels
COVID-19-associated pneumonia ✔ (Pleuritic) ✔ (Usually high) - Increased inflammatory markers, including ESR, hs-CRP
COVID-19-associated acute respiratory distress syndrome - -
  • Signs of RV dysfunction/RV dilatation may be seen.
-
COVID-19-associated pulmonary embolism ✔ (Usually sudden-onset) ✔ (Pleuritic) ✔ (If massive PE) ✔ (Low-grade)
  • Non-specific:may show S1Q3T3 pattern
  • May show signs of RV strain, RV dilatation, RV dysfunction (if large PE)
  • On CT angiography: Intra-luminal filling defect
  • On MRI: Narrowing of involved vessel
  • No contrast seen distal to obstruction
  • Polo-mint sign (partial filling defect surrounded by contrast)


References